tiprankstipranks
Trending News
More News >
Molecule Holdings (TSE:MLCL)
:MLCL
Canadian Market

Molecule Holdings (MLCL) Income Statement

Compare
6 Followers

Molecule Holdings Income Statement

Last quarter (Q3 2023), Molecule Holdings's total revenue was C$714.28K, a decrease of -5.77% from the same quarter last year. In Q3, Molecule Holdings's net income was C$-786.94K. See Molecule Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19
Total Revenue
C$ 1.97MC$ 455.26KC$ 0.00C$ 0.00
Gross Profit
C$ -1.07MC$ -499.74KC$ -47.98KC$ -27.99K
Operating Expenses
C$ 2.80MC$ 2.89MC$ 1.83MC$ 1.10M
Depreciation and Amortization
C$ 39.77KC$ 567.06KC$ 47.98KC$ 27.99K
EBITDA
C$ -3.87MC$ -3.00MC$ -3.23MC$ -1.05M
Operating Income
C$ -3.91MC$ -3.39MC$ -3.22MC$ -1.08M
Other Income/Expenses
C$ -629.56KC$ -837.27KC$ -1.40MC$ 5.86K
Pretax Income
C$ -4.54MC$ -4.23MC$ -3.33MC$ -1.09M
Net Income
C$ -4.54MC$ -4.89MC$ -1.98MC$ -1.11M
Per Share Metrics
Basic EPS
C$ -0.05C$ -0.05C$ -0.03C$ -0.24
Diluted EPS
C$ -0.05C$ -0.05C$ -0.03C$ -0.24
Weighted Average Shares Outstanding
97.11M 91.86M 75.71M 4.66M
Weighted Average Shares Outstanding (Diluted)
97.11M 91.86M 75.71M 4.66M
Currency in CAD

Molecule Holdings Earnings and Revenue History